MedNet Solutions Announces iMedNet, the Company's Next Generation EDC Technology Platform
MedNet Solutions, a global life sciences technology solutions company specializing in clinical
study management systems, is pleased to announce iMedNet™, the company’s ground‐breaking new electronic data
capture (EDC)/eClinical technology platform. Developed based on MedNet’s extensive, decade‐long experience
supporting world‐wide clinical trials and registries, iMedNet is a next generation, Web 2.0‐based EDC solution built
using the most advanced and powerful technology tools available.
“iMedNet is an exciting and innovative new data management system that gives our customers the power to build
their own studies,” stated Paul D. Grady, Chief Technology Officer at MedNet Solutions. “It provides a flexible and
intuitive ‘drag and drop’ environment to set up forms, business logic, workflows and protocols, utilizing a reusable
component library. Study creation and deployment can now occur in a matter of days.”
iMedNet delivers a secure, community‐based infrastructure supporting effective collaboration and communication
among all clinical study constituents – from study administrators, data managers and monitors, to investigators,
research coordinators and patients. The system is easily accessible through the MedNet Cloud from any Internet enabled PC anywhere in the world. iMedNet provides a standards‐based, scalable EDC platform that can efficiently support any type of study (from Phase I trials to post market registries) at a highly competitive price point.
“We’re extremely excited about the benefits that iMedNet will bring to the life science industry,” commented John
M. (Rob) Robertson, president and CEO of MedNet Solutions. “Combining iMedNet’s industry‐leading technology
with its pay‐as‐you‐go, SaaS pricing model will significantly lessen the administrative burden and costs traditionally
associated with EDC solutions.”
The iMedNet system, which is currently in the beta‐testing phase, will first be available for preview at the eClinical
Technology Summit, scheduled for April 12‐14, 2010 at the Orlando World Center Marriott in Orlando, Florida.
General availability of the iMedNet technology solution is scheduled for the 3rd quarter of 2010.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
